(PharmaNewsWire.Com, October 10, 2017 ) According to the report Latin America Cancer Monoclonal Antibodies Market, published by Market Data Forecast, The Global market has been estimated at USD 3.24 billion in 2015 and is projected to reach USD 5.1 billion by the end of 2020, at a CAGR of 9.5% during the forecast period from 2015 to 2020
Cancer is a severe diseases causing millions of death worldwide every year. Cancer starts from a single cell and genetically transforms a normal cell in to tumour cell and is gradually spread to other cells. With the dramatic increase in the number of people affected by cancer, many pharmaceutical players started to invest on monoclonal antibodies. While the drugs are used for the treatment of cancer, drugs like chemotherapy agents have adverse side effects as they affect the normal cells as well along with cancerous cells. This prompted the increased usage of Monoclonal Antibodies for the treatment of cancer.
Recent years have seen the emergence of monoclonal antibodies market, offering less toxic and highly efficient therapeutics alternatives. The antibody agents are used to cure a wide array of diseases, especially cancer, autoimmune and inflammatory diseases. They are mono-specific antibodies having identical immune cells that are clone to the single parent cells and are directed to a specific target cell. This customizable feature of the antibodies due to its specific nature can play a critical role in eliminating the cancer cell while sparing the healthy cells. Monoclonal antibodies are more effective in treating cancer than their counter parts like drugs or chemotherapy owing to their adverse side effects.
Latin America Cancer Monoclonal Antibodies Market : Segmentation
By Application
By Type Conjugate Cancer Therapies
• Geographical Analysis
Brazil Mexico Rest of Latin America
The major players in the Cancer Monoclonal Antibodies Market
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
